Latest filing published 13 Nov 2023 for Intercept Pharmaceuticals, INC., €267k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David A. Ford, listed as senior executive, appears in our data through filings on Intercept Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 8 filings, for trades running from 8 May 2021 to 8 November 2023.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 13 November 2023 with a transaction (€267k) in Intercept Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations